Synexis LLC announced two strategic initiatives that highlight the company's focus and future growth in the healthcare market. Synexis has entered a strategic partnership...
SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, announced dosing of the first human subjects in its phase 1 clinical...
Keymed Biosciences announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or...
Athonet, a global leader in private network technology, and BearCom, a wireless integrator, are working together to bring private LTE, 5G and CBRS (Citizens...
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, announced that it has secured a $15 million term loan from...
